The investigation and management of interstitial cystitis

Journal of the British Menopause Society

Volumn 11, Issue 4, 2005, Pages 132-139

  Parsons, Matthew ^a   Toozs Hobson, Philip ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Bladder; Chronic pelvic pain syndrome; Inflammation; Interstitial cystitis; Painful bladder syndrome

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BCG VACCINE; CAFFEINE; CHONDROITIN; DIMETHYL SULFOXIDE; HEPARIN; HYALURONIC ACID; HYDROXYZINE; PENTOSAN POLYSULFATE; RESINIFERATOXIN;

ABDOMINAL PAIN; ALCOHOL CONSUMPTION; BLADDER DISEASE; BLADDER DISTENSION; BLADDER RECONSTRUCTION; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYSTECTOMY; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MECHANISM; DYSURIA; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION; MORBIDITY; PATIENT CARE; PELVIS PAIN SYNDROME; PERINEUM; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY; SYSTEMIC THERAPY; TREATMENT FAILURE; URETHRAL PAIN; URINARY DIVERSION; URINARY FREQUENCY; URINARY URGENCY; VAGINA PAIN;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYSTITIS, INTERSTITIAL; DIAGNOSIS, DIFFERENTIAL; DIET; FEMALE; HEALTH EDUCATION; HUMANS; QUALITY OF LIFE; WOMEN'S HEALTH;

EID: 30944464068     PISSN: 13621807     EISSN: 13621807     Source Type: Journal    
DOI: 10.1258/136218005775544255     Document Type: Review

References (63)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78
2. Hanno P. Definition and Diagnosis: Where We Are in 2003? Interstitial Cystitis Epidemiology Task Force Meeting, National Institute of Diabetes and Digestive and Kidney Diseases. October 2003, Maryland USA. See http://www.niddk.nih.gov/fund/other/archived-conferences/2003/ic/ TaskForce_MeetingReport.pdf (last accessed 6 October 2005)
3. Parsons CL. Interstitial cystitis. In: Kursh ED, Mcguire EJ, eds. Female Urology. Philadelphia: Lippincott, 1994: 421-38
4. Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol 1999;161: 549-52
5. Leppilahti M, Tammela TL, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 2002; 168:139-43
6. Kurth KH. Interstital Cystitis. Berlin: Ergebnisse Verlag, 2004: 39-53
7. Tincello DG, Walker AC. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Europ J Obstet Gynecol Reprod Biol 2005;118:91-5
8. Irwin PP, Takei M, Sugino Y. Summary of the urodynamics workshops on IC Kyoto, Japan. Int J Urol 2003;10:S19-23
9. Erickson DR. Painful bladder syndrome. In: Cardozo LD, Staskin D, eds. Textbook of Female Urology and Urogynaecology. 2nd edn. Oxford: Isis Medical Media (in press)
10. Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis, gynaecologic pelvic pain, prostatitis, and their epidemiology. Int J Urol 2003;10:S3-6
11. Porru D, Politano VA, Gerardini M. Different clinical presentations of interstitial cystitis syndrome. Int Urogynecol J Pelvic. Floor Dysfunct 2004;15:198-202
12. Duldulao KE, Diokno AC, Mitchell B. Value of urinary cytology in women presenting with urge incontinence and/or irritative voiding symptoms. J Urol 1997;157:113-16
13. Ito T, Tomoe H, Ueda T, Yoshimura N, Sant G, Hanno P. Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease. Int J Urol 2003;10 (Suppl):S24-6
14. Keller ML, McCarthy DO, Neider RS. Measurement of symptoms of interstitial cystitis: a pilot study. Urol Clin North Am 1994;21:67-72
15. Goin JE, Olalye D, Peters KM, Steinert B, Habicht K, Wynant G. Psychometric analysis of the University of Wisconsin interstitial cystitis scale: implications for use in randomized clinical trials. J Urol 1998;159:1085-90
16. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The Interstitial Cystitis Symptom Index and Problem Index. Urol 1997;49 (Suppl 5A):58-63
17. Lubeck DP, Whitmore K, Sant GR, Alvarez-Horine S, Lai C. Psychometric validation of the O'Leary-Sant Interstitial Cystitis Symptom Index in a clinical trial of pentosan polysulfate sodium. Urol 2003;57 (Suppl 6A):62-6
18. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic, and gynaecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urol 2002;60:573-8
19. Nordling J. Interstitial cystitis: how should we diagnose it and treat it in 2004? Curr Opin Urol 2004;14:323-7
20. Erickson DR, Xie SX, Bhavanandan VP, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol 2002;167: 2461-9
21. Ehren I, Hosseini A, Lundberg JO. Nitric oxide: a useful gas in the detection of lower urinary tract inflammation. J Urol 1999;162:327-9
22. Hosseini A, Ehren I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol 2004;172:2261-5
23. Abrams P, Fenely R, Torrens M. Patient assessment. In: Abrams P, Fenely R, Torrens M, eds. Urodynamics (1st edn). New York: Springer, 1983: 6-27
24. Palnæs Hansen C, Klarskov P. The accuracy of the frequency-volume chart: comparison of self-reported and measured volumes. Br J Urol 1998;81:709-11
25. Mazurick CA, Landis JR. Evaluation of repeat daily voiding measures in the National Interstitial Cystitis Data Base Study. J Urol 2000;163:1208-11
26. Kirkemo A, Peabody M, Diokno AC, et al. Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997;49 (Suppl):76-80
27. Diokno AC, Wells TJ, Brink CA. Comparison of self-reported voided volume with cystometric bladder capacity. J Urol 1987; 137:698-700
28. Parsons CL, Forrest J, Nickel JC, et al. Effect of pentosan polysulphate on intravesical potassium sensitivity. Urology 2002; 59:329-33
29. Parsons CL, Greenberger M, Gabal L, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998; 159:1862-7
30. Kuo HC. Urodynamic study and potassium sensitivity test for women with frequency-urgency syndrome and interstitial cystitis. Urol Int 2003;71:61-5
31. Nickel CJ. Controversies and trends in the diagnosis and treatment of interstitial cystitis. Bladder master class, London, 23 June 2005
32. Tissot WD, Diokno AC, Peters KM. A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004;172:478-80
33. Nordling J, Anjum FH, Bade JJ, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 2004;45:662-9
34. Rosamilia A, Igawa Y, Higashi S. Pathology of interstitial cystitis. Int J Urol 2003;10 (Suppl):S11-15
35. Erickson DR, Tomaszewski JE, Kunselman AR. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol 2005;173:93-7
36. Bade J, Ishizuka O, Yoshida M. Future research needs for the definition/ diagnosis of interstitial cystitis. Int J Urol 2003;10 (Suppl):S31-4
37. Nordling J, et al. European Copenhagen Workshop on Interstitial Cystitis (IC). Eur Urol 2004;45:662-9
38. Executive Committee Summary and Task Force Meeting Report. Bethesda, 29 October 2003. See http://www.niddk.nih.gov/fund/other/archived-conferences/2003/ic/ TaskForce_Meeting_Report.pdf (last accessed 21 October 2005)
39. Kahn BS, Stanford EJ, Mishell DR Jr, et al. Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: a consensus report. Curr Med Res Opin 2005;21:509-16
40. Rovner E, Propert KJ, Brensinger C, et al. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 2000;56:940-5
41. Lukban JC, Whitmore KE, Sant GR. Current management of interstitial cystitis. Urol Clin North Am 2002;29:649-60
42. The Cystitis and Overactive Bladder Foundation. See http//www.interstitialcystitis.co.uk/medicalconditions/IC/ triggerfoods.htm (last accessed 21 October 2005)
43. The Interstitial Cystitis Association. See http://www.ichelp.org/TreatmentAndSelfHelp/ICAndDiet.htm (last accessed 21 October 2005)
44. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 2005;66:494-9
45. Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 1988;140:36-9
46. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994;73:504-7
47. Perez-Marrero R, Emerson LE, Maharajh DO, Juma S. Prolongation of response to DMSO by heparin maintenance. Urology 1993;41 (Suppl):64-6
48. Holm-Bentzen M, Jacobsen F, Nerstrom B, et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 1987;138:503-7
49. Parsons CL, Benson G, Childs SJ, et al. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993;150: 845-8
50. Nickel JC, Barkin J, Forrest J, et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005;65:654-8
51. Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997;49 (Suppl 5A):111-13
52. Nordling J, Jorgensen S, Kallestrup E. Cystistat for the treatment of interstitial cystitis: a 3-year follow-up study. Urology 2001;57 (Suppl 1):123
53. Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 2002;9: 1454-8
54. Mayer R, Propert KJ, Peters KM, et al. A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis. J Urol 2005;173:1186-91
55. Peters K, Diokno A, Steinert B, et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol 1997;157:2090-4
56. de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 women with spinal cord lesions. Neurourol Urodyn 1998;17:513-23
57. Maggi CA. The dual, sensory and 'efferent' function of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In: Maggi CA, ed. The Autonomic Nervous System. Vol. 3: Nervous Control of the Urogenital System. Chur, Switzerland: Harwood Academic Publishers, 1993:383-422
58. Payne CK, Mosbaugh PG, Forrest JB, et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005; 173:1590-4
59. Bryson HM, Wilde MI. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 1996;8:459-76
60. Hanno PM. Amitriplyline in the treatment of interstitial cystitis. Urol Clin North Am 1994;21:89-91
61. van Uphoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004;172:533-6
62. Minogiannis P, El-Mansoury M, Betances JA. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol 1998;20:553-63
63. Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology 1997;49 (Suppl):108-10